Overcoming Immunoescape Mechanisms of BCL1 Leukemia and Induction of CD8(+) T-Cell-Mediated BCL1-Specific Resistance in Mice Cured by Targeted Polymer-Bound Doxorubicin

Abstract

Our results show that identifying the immunoescape mechanisms used by the particular tumor to evade immune response could be very importatnt for the therapy.

Keywords

• Leukemia
• doxorubicin
• tumor
• mouse model
• immunotherapy